Treatment Patterns and Clinical Outcomes Among Indian Patients Receiving Palbociclib Combinations for HR+/HER2- Advanced/Metastatic Breast Cancer in Real World Settings
Latest Information Update: 07 Dec 2023
At a glance
- Drugs Palbociclib (Primary)
- Indications Advanced breast cancer; HER2 negative breast cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer
Most Recent Events
- 20 Oct 2022 New trial record